Lexicon Pharmaceuticals Newsroom

Citi Maintains Lexicon Pharmaceuticals(LXRX.US) With Buy Rating, Cuts Target Price to $1.2

Moomoo NewsNov 27 16:31 ET

Analysts Conflicted on These Healthcare Names: Lexicon Pharmaceuticals (LXRX), Halozyme (HALO) and Crinetics Pharmaceuticals (CRNX)

TipRanksNov 27 00:45 ET

H.C. Wainwright Maintains Lexicon Pharmaceuticals(LXRX.US) With Buy Rating, Maintains Target Price $4

Moomoo NewsNov 26 10:31 ET

Needham Maintains Lexicon Pharmaceuticals(LXRX.US) With Hold Rating

Moomoo NewsNov 22 13:31 ET

Lexicon Pharmaceuticals Analyst Ratings

BenzingaNov 22 13:03 ET

HC Wainwright Cuts Price Target on Lexicon Pharmaceuticals to $4 From $6, Maintains Buy Rating

MT NewswiresNov 22 11:45 ET

Piper Sandler Maintains Lexicon Pharmaceuticals(LXRX.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsNov 13 08:36 ET

Lexicon Pharmaceuticals (LXRX) Gets a Buy From Piper Sandler

TipRanksNov 13 08:21 ET

H.C. Wainwright Maintains Lexicon Pharmaceuticals(LXRX.US) With Buy Rating, Maintains Target Price $6

Moomoo NewsNov 13 07:35 ET

Needham Maintains Lexicon Pharmaceuticals(LXRX.US) With Hold Rating

Moomoo NewsNov 13 05:38 ET

Lexicon Pharmaceuticals Analyst Ratings

BenzingaNov 13 05:22 ET

Analysts Conflicted on These Healthcare Names: Neumora Therapeutics, Inc. (NMRA), ICU Medical (ICUI) and Lexicon Pharmaceuticals (LXRX)

TipRanksNov 13 05:22 ET

Lexicon Pharmaceuticals Analyst Ratings

BenzingaNov 5 09:48 ET

H.C. Wainwright Maintains Lexicon Pharmaceuticals(LXRX.US) With Buy Rating, Maintains Target Price $6

Moomoo NewsNov 4 12:31 ET

Lexicon Pharma Is Maintained at Buy by HC Wainwright & Co.

Dow JonesNov 1 07:10 ET

H.C. Wainwright Maintains Lexicon Pharmaceuticals(LXRX.US) With Buy Rating, Cuts Target Price to $6

Moomoo NewsNov 1 06:36 ET

Needham Maintains Lexicon Pharmaceuticals(LXRX.US) With Hold Rating

Moomoo NewsNov 1 05:33 ET

Leerink Partners Maintains Lexicon Pharmaceuticals(LXRX.US) With Buy Rating

Moomoo NewsOct 30 08:31 ET

H.C. Wainwright Maintains Lexicon Pharmaceuticals(LXRX.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsOct 30 07:31 ET

Lexicon Pharmaceuticals Analyst Ratings

BenzingaOct 30 05:58 ET